3Fong DS, A iello L, Gardner Tw, et al. American diabetes associa- tion diabetic retinopathy (Review) [J]. Diabetes lare, 2003,26 (1) : 226-229.
4Stitt AW, Moore JE, Sharkey JA, et al. Advanced glycationend products in vitreous., structure and functional implicationsfor dia- betic vitreopathy [J]. Invest Ophthalmol Vis Sci, 1998,39.. 2517- 2523.
5Newton A. Protein Kinase C .. Strucre, function and regulation[J ], Biol ehem, 1995,278(48) :28495.
6Koya D King,GL Protein, Kinase C. Activation and the develop- ment of diabetic eomplications[J]. Diabetes, 1998,47 : 859-866.
7Pomero F,Allione A,Beltramo M,et al. Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes[J ]. Diabetologia, 2003,46 : 416-419.
8Demirann, Sefran BG, Soylum, et al . Detem ination of vitreous in terleuk in -- 1 (IL-- 1) and turn our necrosis factor levels in prolifer- ative diabetic retinopahy[J]. Eye,2006,20(12) : 1366-1369.
9Vincent JA,Mohr S. Inbihition of caspase --1/in terlenk in --1 be- ta signaling revents degeneration of retinal capillaries in diabetes and galactosem ia[J]. Diabetes, 2007,56 (1) : 224-230.
10Park HK, Ahn CW,Lee GT, et al. Polymorphism of aldose reduc- tase gene and diabetic microvascular complications in type 2 dia- betesmellitus[J]. Diabetes Res Clin Pract,2002,55(2) :151-157.
